Network origin in Thomas Glover first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Vasca, Inc.
 Vasca, Inc. Medical SpecialtiesHealth Technology Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA.
1
| Private Company | Medical Specialties | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Glover via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Cardiva Medical, Inc.
 Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | Medical Specialties | Corporate Officer/Principal | |
| Tulane University (Louisiana) | College/University | Undergraduate Degree | |
| Loyola University New Orleans | College/University | Masters Business Admin | |
| Ethicon Biosurgery Ireland | Sales & Marketing | ||
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Johnson & Johnson Pharmaceutical Group | Sales & Marketing | ||
Cordis Cardiology
 Cordis Cardiology Miscellaneous Commercial ServicesCommercial Services Part of Cardinal Health, Inc., Cordis Cardiology engages in development and manufacturing of interventional cardiovascular and endovascular technologies. The company is based in Miami Lakes, FL. The CEO of the company is Shar Matin. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Enmedia, Inc. | Corporate Officer/Principal | ||
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal | |
| IBM | Packaged Software | Corporate Officer/Principal | |
Carmell Regen Med Corp.
 Carmell Regen Med Corp. Pharmaceuticals: OtherHealth Technology Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Other | Chief Executive Officer | |
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Biotechnology | Director/Board Member | |
| CARMELL CORPORATION | Household/Personal Care | Chief Executive Officer |
Statistics
International
| United States | 13 |
| Ireland | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
| Technology Services | 2 |
| Consumer Non-Durables | 2 |
Operational
| Corporate Officer/Principal | 6 |
| Sales & Marketing | 3 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| President | 2 |
Most connected contacts
| Insiders | |
|---|---|
| Randy Hubbell | 14 |
- Stock Market
- Insiders
- Thomas Glover
- Company connections
